This article has been updated with a comment from Ethicon. An Indiana federal appeals court yesterday upheld a $20 million jury award in a pelvic mesh case against Johnson & Johnson’s (NYSE:JNJ) Ethicon unit. Despite the “flurry of arguments” in its appeal, the company failed to convince the three-judge panel that it should overturn the […]
Implants
FDA clears Cleveland Clinic 3D-printed airway stents
The FDA recently cleared 3D-printed, patient-specific stents developed by a doctor at the Cleveland Clinic. Cleveland Clinic physician Tom Gildea developed the stents to keep open the airways of patients with serious breathing disorders caused by inflammation, trauma, tumors and other masses. Airway stents come in a limited number of sizes and shapes and are […]
Arthrosuface sold to Anika Therapeutics for $100m
Primo Medical Group announced that it completed the $100 million sale of spin-off company Arthrosurface to Anika Therapeutics (NSDQ:ANIK). Under the agreement, Anika is set to acquire all outstanding shares of Arthrosurface in exchange for $100 million in total, starting with an upfront payment of approximately $60 million in cash from Anika’s existing balance sheet. The […]
Miles White’s fearless strategy for growing Abbott
With strong leadership and a taste for risk-taking, outgoing CEO Miles White left no stone unturned as he grew Abbott into one of the world’s largest medical device companies. Few medical device companies have seen the growth and transformation that Abbott (NYSE:ABT) has seen under the leadership of Miles White. During his two decades as […]
BlueWind Medical appoints new CEO
Neurostimulation device company BlueWind Medical has appointed its chairman of the board Daniel Lemaitre as its new CEO, effective last week on Jan. 1. Lemaitre has served as BlueWind Medical’s chairman of the board since November 2018. He’s also a board member of Globus Medical as well as chairman of Endologix. The industry veteran was […]
Teleflex’s UroLift wins new FDA designation
Teleflex (NYSE:TFX) said today that the FDA has granted the company an expanded indication for the use of its UroLift system to treat larger prostates, between 80cc and100cc. UroLift is a minimally invasive, in-office treatment designed to provide rapid relief and recovery from the symptoms of benign prostatic hyperplasia (BPH), or enlarged prostate. Symptoms may […]
Medtronic wins dismissal of Pennsylvania couple’s DBS lawsuit
Medtronic has prevailed in a personal injury lawsuit over a deep-brain stimulation implant approved by the FDA to treat neurological disorders. A federal judge in Philadelphia on Monday granted the company’s motion to dismiss the lawsuit filed by Edward Walls and his wife, Tonya Chavis-Walls. The couple had claimed in Pennsylvania state court that two […]
Medtronic pain pump recall deemed Class I
The FDA has classified the recall of Medtronic’s (NYSE:MDT) SynchroMed II implantable drug pumps as Class I, the most serious type of recall. The company announced the voluntary recall in October, saying that it had received complaints about the pumps’ motors stalling permanently. Permanent motor stall could prevent the infusion of drugs to the patient, […]
Garwood Medical Devices’ Series B round oversubscribes by $700,000
Garwood Medical Devices announced last week that it closed its Series B financing round at $3.7 million. The round was oversubscribed by $700,000. The Buffalo, N.Y.-based medical device developer closed the funding round on Nov. 30. The WNY ImpactInvestment fund contributed $500,000 to the Series B, while 17 investors from the company’s $3.6 million Series […]
FDA clears Cochlear piezoelectric hearing implant
The FDA has cleared a second-generation pioezoelectric bone-conduction hearing implant from Cochlear (ASX:COH), the company announced today. The Osia 2 system is an active osseointegrated, steady-state implant (OSI) that uses digital piezoelectric stimulation to bypass damaged areas of the natural hearing system to send sound vibrations directly to the inner ear. It is designed to […]
Mayo Clinic, W.L. Gore team up on stem cell therapy treatments
Mayo Clinic and W. L. Gore & Associates have announced a partnership to develop implantable cell therapies to treat debilitating conditions with no cure. The for-profit company, Avobis Bio, will combine a patient’s own stem cells with bioabsorbable scaffolds to stimulate the healing of perianal fistulas, painful tunneling wounds that affect patients with Crohn’s disease. […]